VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $808,538 | -14.5% | 30,046 | -4.4% | 0.18% | -15.3% |
| Q2 2023 | $945,876 | -7.6% | 31,414 | -0.7% | 0.22% | -16.9% |
| Q1 2023 | $1,023,748 | +15.0% | 31,646 | +1.9% | 0.26% | -10.0% |
| Q4 2022 | $889,843 | +45.2% | 31,048 | +22.1% | 0.29% | +39.6% |
| Q3 2022 | $613,000 | -9.7% | 25,432 | +2.6% | 0.21% | -6.3% |
| Q2 2022 | $679,000 | -29.6% | 24,782 | -1.5% | 0.22% | -21.9% |
| Q1 2022 | $965,000 | +22.9% | 25,165 | +2.7% | 0.28% | +25.2% |
| Q4 2021 | $785,000 | +9.9% | 24,503 | +1.1% | 0.23% | -3.4% |
| Q3 2021 | $714,000 | -3.0% | 24,240 | +11.9% | 0.23% | -4.5% |
| Q2 2021 | $736,000 | +154.7% | 21,670 | +143.3% | 0.24% | +113.0% |
| Q1 2021 | $289,000 | -13.7% | 8,907 | -4.3% | 0.12% | -29.4% |
| Q4 2020 | $335,000 | -1.2% | 9,310 | +7.4% | 0.16% | -18.9% |
| Q3 2020 | $339,000 | – | 8,668 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |